Kurdi et al., 2016 - Google Patents
Tiam1/Rac1 complex controls Il17a transcription and autoimmunityKurdi et al., 2016
View HTML- Document ID
- 1715492821532583592
- Author
- Kurdi A
- Bassil R
- Olah M
- Wu C
- Xiao S
- Taga M
- Frangieh M
- Buttrick T
- Orent W
- Bradshaw E
- Khoury S
- Elyaman W
- Publication year
- Publication venue
- Nature communications
External Links
Snippet
RORγt is a master transcription factor of Th17 cells and considered as a promising drug target for the treatment of autoimmune diseases. Here, we show the guanine nucleotide exchange factor, Tiam1, and its cognate Rho-family G protein, Rac1, regulate interleukin (IL) …
- 101700023645 RAC1 0 title abstract description 175
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kurdi et al. | Tiam1/Rac1 complex controls Il17a transcription and autoimmunity | |
Wilson et al. | Neutrophil extracellular traps and their histones promote Th17 cell differentiation directly via TLR2 | |
Sahoo et al. | Batf is important for IL-4 expression in T follicular helper cells | |
Karki et al. | NLRC3 is an inhibitory sensor of PI3K–mTOR pathways in cancer | |
Boshuizen et al. | Reversal of pre-existing NGFR-driven tumor and immune therapy resistance | |
Huynh et al. | Bhlhe40 is an essential repressor of IL-10 during Mycobacterium tuberculosis infection | |
Cytlak et al. | Ikaros family zinc finger 1 regulates dendritic cell development and function in humans | |
Ji et al. | Long non-coding RNA Lnc-Tim3 exacerbates CD8 T cell exhaustion via binding to Tim-3 and inducing nuclear translocation of Bat3 in HCC | |
Xiao et al. | DKK2 imparts tumor immunity evasion through β-catenin-independent suppression of cytotoxic immune-cell activation | |
Mendoza et al. | Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells | |
Khan et al. | PD-L1hi B cells are critical regulators of humoral immunity | |
Vogelpoel et al. | Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages | |
Wang et al. | Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+ Treg cells in pancreatic ductal adenocarcinoma | |
Moon et al. | In vivo action of IL-27: reciprocal regulation of Th17 and Treg cells in collagen-induced arthritis | |
Wang et al. | Interleukin-10 deficiency impairs regulatory T cell-derived neuropilin-1 functions and promotes Th1 and Th17 immunity | |
Kellner | Targeting interleukin-17 in patients with active rheumatoid arthritis: rationale and clinical potential | |
Seri et al. | Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate isomerase-induced arthritis model | |
Yang et al. | PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival | |
Yoon et al. | Phosphorylation status determines the opposing functions of Smad2/Smad3 as STAT3 cofactors in TH17 differentiation | |
Elgueta et al. | CCR6-dependent positioning of memory B cells is essential for their ability to mount a recall response to antigen | |
Evans et al. | TNF-α blockade induces IL-10 expression in human CD4+ T cells | |
Tanaka et al. | Trim33 mediates the proinflammatory function of Th17 cells | |
Radomir et al. | The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5 | |
Kim et al. | Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways | |
Torrey et al. | Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome |